| # | Drug | Count |
|---|---|---|
| 0 | NILOTINIB | 498 |
| 1 | IMATINIB | 275 |
| 2 | DASATINIB | 216 |
| 3 | BOSUTINIB | 110 |
| 4 | IMATINIB MESYLATE | 91 |
| 5 | HYDROXYUREA | 55 |
| 6 | ASCIMINIB | 51 |
| 7 | FUROSEMIDE | 29 |
| 8 | PONATINIB HYDROCHLORIDE | 28 |
| 9 | CYCLOPHOSPHAMIDE | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CAMPHOR, MENTHOL, AND METHYL SALICYLATE | 1 | 0.1250 |
| 1 | DASATINIB | 216 | 0.0232 |
| 2 | NILOTINIB | 498 | 0.0168 |
| 3 | ASCIMINIB | 51 | 0.0146 |
| 4 | BOSUTINIB | 110 | 0.0122 |
| 5 | DEXTROSE AND SODIUM CHLORIDE | 2 | 0.0120 |
| 6 | CAPSICUM ANNUUM, FUCUS VESICULOSUS, BORAGE OFFICINALIS, LECITHIN, CALCAREA CARBONICA, FERRUM METALLICUM, KALI BICHROMICUM, KALI CARBONICA, PULSATILLA (PRATENSIS), SULPHUR | 1 | 0.0114 |
| 7 | TELMISARTAN AND AMLODIPINE | 1 | 0.0100 |
| 8 | PONATINIB HYDROCHLORIDE | 28 | 0.0053 |
| 9 | IMATINIB MESYLATE | 91 | 0.0033 |
| # | Drug class | Count |
|---|---|---|
| 0 | Kinase Inhibitor [EPC] | 230 |
| 1 | Antimetabolite [EPC] | 55 |
| 2 | Corticosteroid [EPC] | 44 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 40 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 39 |
| 5 | Alkylating Drug [EPC] | 30 |
| 6 | Loop Diuretic [EPC] | 29 |
| 7 | Aromatase Inhibitor [EPC] | 26 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 25 |
| 9 | Proton Pump Inhibitor [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 4 | 0.0013 |
| 1 | Somatostatin Analog [EPC] | 7 | 0.0010 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 3 | Asparagine-specific Enzyme [EPC] | 8 | 0.0006 |
| 4 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 5 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 6 | Kinase Inhibitor [EPC] | 230 | 0.0004 |
| 7 | Provitamin D2 Compound [EPC] | 11 | 0.0004 |
| 8 | Phosphodiesterase 3 Inhibitor [EPC] | 2 | 0.0003 |
| 9 | Estrogen Receptor Antagonist [EPC] | 13 | 0.0003 |